TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15839961

Group type: EXPERIMENTAL
Intervention: Circular stapled haemorrhoidectomy under local anaesthesia
Number of subjects: 60

Group type: COMPARATOR
Intervention: Circular stapled haemorrhoidectomy under regional anaesthesia
Number of subjects: 60
Study: 11940691

Group type: EXPERIMENTAL
Intervention: Nimesulide 100 mg by mouth twice daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 40
Study: 9789918

Group type: EXPERIMENTAL
Intervention: Intervention methods for community trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Permutation tests
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard Mantel-Haenszel methods
Number of subjects: 0
Study: 7631673

Group type: COMPARATOR
Intervention: Observation phase (no treatment)
Number of subjects: 1260

Group type: EXPERIMENTAL
Intervention: Treatment phase (clindamycin 300 mg orally twice daily for 7 days)
Number of subjects: 1260

Group type: EXPERIMENTAL
Intervention: Treatment phase (clindamycin for bacterial vaginosis and trichomoniasis)
Number of subjects: 1260
Study: 2483979

Group type: EXPERIMENTAL
Intervention: aprotinin (2 x 10(6) KIU in the pump prime)
Number of subjects: 23

Group type: COMPARATOR
Intervention: placebo treatment
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: aprotinin
Number of subjects: 23
Study: 7412430

Group type: EXPERIMENTAL
Intervention: Attitude instrument for self-care
Number of subjects: 245
Study: 30517071

Group type: EXPERIMENTAL
Intervention: Intensive preventive protocol (subgroups A1, B1, C1) including topical application of fluoride, brushing with 5000-ppm fluoride toothpaste, use of amorphous calcium phosphate-casein phosphopeptide, applications of sealants for occlusal lesions (ICDAS code 2), and minimal resin restorations for occlusal lesions (ICDAS code 3)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Instructions in oral hygiene (subgroups A2, B2, C2)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Intensive preventive protocol (subgroup C1)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Instructions in oral hygiene (subgroup C2)
Number of subjects: 44
Study: 28291239

Group type: EXPERIMENTAL
Intervention: Cap assisted esophagogastroduodenoscopy (CA‐EGD)
Number of subjects: 101
Study: 25826741

Group type: EXPERIMENTAL
Intervention: Nitrate supplementation (beetroot juice; 5 mm, 0.45 g nitrates per day for 3 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Ringer solution)
Number of subjects: 0
Study: 23404145

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open surgery (OS)
Number of subjects: 60
Study: 21830407

Group type: EXPERIMENTAL
Intervention: Preoperative transarterial chemoembolization (TACE)
Number of subjects: 257
Study: 18722627

Group type: EXPERIMENTAL
Intervention: computer-delivered attentional retraining
Number of subjects: 24

Group type: COMPARATOR
Intervention: sham training
Number of subjects: 24
Study: 19286361

Group type: EXPERIMENTAL
Intervention: TPI 1020 (600mcg bid for 2 weeks, then 1200mcg bid for 1 week)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Budesonide (400mcg bid for 2 weeks, then 800mcg bid for 1 week)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: TPI 1020
Number of subjects: 27

Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 27
Study: 15814512

Group type: EXPERIMENTAL
Intervention: Subcutaneous morphine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous morphine infusion
Number of subjects: 0
Study: 11970933

Group type: EXPERIMENTAL
Intervention: Cows' milk
Number of subjects: 1108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1108
Study: 9796226

Group type: EXPERIMENTAL
Intervention: Fragmented presentation of highly typical items
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fragmented items preceded by other fragmented items
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: General presentation form of items
Number of subjects: 0
Study: 7611178

Group type: EXPERIMENTAL
Intervention: Fluorescence in situ hybridization (FISH)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cytology
Number of subjects: 40
Study: 2694339

Group type: COMPARATOR
Intervention: Chloramphenicol (total daily dosage, 2 g) plus placebo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Furazolidone (total daily dosage, 800 mg) plus placebo
Number of subjects: 71

Group type: COMPARATOR
Intervention: Chloramphenicol
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Furazolidone
Number of subjects: 71
Study: 846510

Group type: EXPERIMENTAL
Intervention: Hyaluronidase treatment (administered intravenously after the first electrocardiogram and every six hours for 48 hours)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (no hyaluronidase treatment)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Hyaluronidase treatment
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 11589259

Group type: EXPERIMENTAL
Intervention: Rofecoxib 50 mg
Number of subjects: 393

Group type: COMPARATOR
Intervention: Codeine 60 mg/acetaminophen 600 mg
Number of subjects: 393

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 393
Study: 30801612

Group type: EXPERIMENTAL
Intervention: Breakfast in the classroom with breakfast-specific nutrition education
Number of subjects: 1362

Group type: COMPARATOR
Intervention: Control schools (breakfast before school in cafeteria and standard nutrition education)
Number of subjects: 1362
Study: 29332743

Group type: EXPERIMENTAL
Intervention: 1 minute rest interval (P1)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 3 minute rest interval (P3)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 5 minute rest interval (P5)
Number of subjects: 15
Study: 27348762

Group type: EXPERIMENTAL
Intervention: Candesartan (32 mg/d)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study: 25027230

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA SupremeTM, LMA Company, UK)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Face mask (control group)
Number of subjects: 142
Study: 22210065

Group type: EXPERIMENTAL
Intervention: Self-reported itch characteristics and validated scales for itch sensation, affect of itch, and severity.
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Self-reported itch sensation dimensions.
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Identification of potential itch triggers and relief activities.
Number of subjects: 23
Study: 20227681

Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 538

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Trajectory Group 2 (Amisulpride or Risperidone)
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: Trajectory Group 4 (Amisulpride or Risperidone)
Number of subjects: 538
Study: 17647145

Group type: EXPERIMENTAL
Intervention: Insulin detemir (0.15, 0.3, 0.6 U/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 12

Group type: COMPARATOR
Intervention: NPH insulin (0.15, 0.3, 0.6 IU/kg)
Number of subjects: 12
Study: 15596269

Group type: EXPERIMENTAL
Intervention: Intracervical placement of laminaria
Number of subjects: 50

Group type: COMPARATOR
Intervention: No laminaria
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 50
Study: 12163963

Group type: EXPERIMENTAL
Intervention: Massed practice (20 min) - Group A
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Distributed practice (20 min in 5 min blocks) - Group B
Number of subjects: 41

Group type: COMPARATOR
Intervention: Distributed practice (15 min in 5 min blocks) - Group C
Number of subjects: 41
Study: 10550081

Group type: COMPARATOR
Intervention: Insulin four times daily regimen
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Insulin twice daily regimen
Number of subjects: 394
Study: 7607776

Group type: EXPERIMENTAL
Intervention: Individual interview in the workplace
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Group-administered questionnaire in the workplace
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Telephone interview
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Individual interview off the worksite
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Combination of self-report, urinalysis, and hair analysis
Number of subjects: 1200
Study: 2254836

Group type: EXPERIMENTAL
Intervention: Clindamycin hydrochloride as an adjunct to scaling
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control site (quiescent)
Number of subjects: 9
Study: 366087

Group type: EXPERIMENTAL
Intervention: Chymopapain intradiscally (chemonucleolysis)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo intradiscally
Number of subjects: 66
Study: 31654818

Group type: EXPERIMENTAL
Intervention: hypercapnia (+9 Torr; 5% inspired CO2)
Number of subjects: 17

Group type: COMPARATOR
Intervention: normocapnia (room air)
Number of subjects: 17

Group type: COMPARATOR
Intervention: hypocapnia (−10 Torr; hyperventilation)
Number of subjects: 17
Study: 29535054

Group type: EXPERIMENTAL
Intervention: Nonbiologic simulator
Number of subjects: 41

Group type: COMPARATOR
Intervention: Biologic wet lab
Number of subjects: 41
Study: 26846356

Group type: EXPERIMENTAL
Intervention: Topical steroids alone (Group A)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical and oral steroids (Group B)
Number of subjects: 50
Study: 25307914

Group type: EXPERIMENTAL
Intervention: Herbal rinse
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.2% Chlorhexidine digluconate
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Probiotic rinse
Number of subjects: 60
Study: 22591162

Group type: EXPERIMENTAL
Intervention: Teachers' use of sophisticated vocabulary and complex syntax
Number of subjects: 782

Group type: COMPARATOR
Intervention: Teachers' total amount of talk
Number of subjects: 782
Study: 20444859

Group type: EXPERIMENTAL
Intervention: Etanercept + MTX
Number of subjects: 24

Group type: COMPARATOR
Intervention: MTX
Number of subjects: 24
Study: 17540689

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome present (n=1964/8397, 23.4%)
Number of subjects: 8397

Group type: EXPERIMENTAL
Intervention: Normal weight dysmetabolic subjects (with either diabetes or metabolic syndrome)
Number of subjects: 8397

Group type: EXPERIMENTAL
Intervention: Overweight patients with dysmetabolic status
Number of subjects: 8397

Group type: EXPERIMENTAL
Intervention: Obese patients with dysmetabolic status
Number of subjects: 8397

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome
Number of subjects: 8397
Study: 16390756

Group type: EXPERIMENTAL
Intervention: Applied relaxation
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 38
Study: 11547219

Group type: EXPERIMENTAL
Intervention: Microcomputer nutritional teaching games
Number of subjects: 1876

Group type: COMPARATOR
Intervention: Conventional nutritional teaching
Number of subjects: 1876
Study: 9691860

Group type: EXPERIMENTAL
Intervention: 0.25% S(‐)‐bupivacaine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.5% S(‐)‐bupivacaine
Number of subjects: 75

Group type: COMPARATOR
Intervention: 0.5% RS‐bupivacaine
Number of subjects: 75
Study: 7871235

Group type: EXPERIMENTAL
Intervention: Self-Injurious Behavior Inhibiting System (SIBIS)
Number of subjects: 1

Group type: EXPERIMENTAL
Intervention: Brief treatment sessions
Number of subjects: 1

Group type: COMPARATOR
Intervention: Contingent shock
Number of subjects: 1
Study: 2970498

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of lithium and imipramine
Number of subjects: 0
Study: 31785189

Group type: COMPARATOR
Intervention: Normative Feedback Only (NFO)
Number of subjects: 5476

Group type: COMPARATOR
Intervention: Consequences Feedback Only (CFO)
Number of subjects: 5476

Group type: EXPERIMENTAL
Intervention: Full Personalized Normative Feedback (PNF)
Number of subjects: 5476
Study: 31075462

Group type: EXPERIMENTAL
Intervention: Retrievable inferior vena cava (IVC) filter placement
Number of subjects: 3295

Group type: COMPARATOR
Intervention: Control group (no filter placement)
Number of subjects: 3295

Group type: COMPARATOR
Intervention: Anticoagulation therapy (without filter placement)
Number of subjects: 3295
Study: 28320685

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1800

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 1800
Study: 26493425

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (10 sessions of 90 minutes)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 23872222

Group type: EXPERIMENTAL
Intervention: Fludarabine 120 mg/m(2) + Melphalan 100 mg/m(2) (FM100)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fludarabine 120 mg/m(2) + Melphalan 140 mg/m(2) (FM140)
Number of subjects: 50
Study: 21876972

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (group D, n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (group C, n = 30)
Number of subjects: 60
Study: 19926042

Group type: EXPERIMENTAL
Intervention: Transradial approach
Number of subjects: 1024

Group type: COMPARATOR
Intervention: Transfemoral approach
Number of subjects: 1024
Study: 16579891

Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol, 600 g
Number of subjects: 0
Study: 12620438

Group type: EXPERIMENTAL
Intervention: E(2) 1 mg/NETA 0.5 mg
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: E(2) 1 mg/NETA 0.25 mg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 11144444

Group type: EXPERIMENTAL
Intervention: 3000 IU vitamin A and 5 IU vitamin E supplementation for 3 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (similar viscosity and organoleptic characteristics)
Number of subjects: 0
Study: 9080357

Group type: EXPERIMENTAL
Intervention: Impedance cardiography
Number of subjects: 20

Group type: COMPARATOR
Intervention: Calibrated finger pulse pressure recordings (Portapres 2)
Number of subjects: 20
Study: 8196848

Group type: EXPERIMENTAL
Intervention: SCMC‐Lys (750 mg/die in a linctus formula for 10 days and 2.7 g in a granular formula once a day for a maximum of 15 days)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 3148381

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion
Number of subjects: 45

Group type: COMPARATOR
Intervention: Intensive subcutaneous insulin injections
Number of subjects: 45
Study: 31862329

Group type: EXPERIMENTAL
Intervention: Advisory CDSS
Number of subjects: 16310
Study: 29473351

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) with low frequency (2 Hz) for 14 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) with high frequency (100 Hz) for 14 days
Number of subjects: 60
Study: 26756390

Group type: EXPERIMENTAL
Intervention: 4CMenB (246Con)
Number of subjects: 1588

Group type: EXPERIMENTAL
Intervention: 4CMenB (246Int)
Number of subjects: 1588

Group type: EXPERIMENTAL
Intervention: 4CMenB (234Con)
Number of subjects: 1588

Group type: COMPARATOR
Intervention: Control (4CMenB-naïve)
Number of subjects: 1588

Group type: EXPERIMENTAL
Intervention: 4CMenB (all recipients)
Number of subjects: 1588
Study: 24720694

Group type: COMPARATOR
Intervention: pdFIX (Immunine®)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: rFIX (Bax326)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Comparison of Immunine® and Bax326
Number of subjects: 44
Study: 23107831

Group type: EXPERIMENTAL
Intervention: Performance-based financing (PBF)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Support plus incentives
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Support alone
Number of subjects: 217

Group type: COMPARATOR
Intervention: International support
Number of subjects: 217
Study: 20205606

Group type: EXPERIMENTAL
Intervention: Sequential therapy (SQT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard triple therapy (STT)
Number of subjects: 0
Study: 25160919

Group type: EXPERIMENTAL
Intervention: Mental support (provided by a friend)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Presence of a friend
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Mental activation of a friend
Number of subjects: 100

Group type: COMPARATOR
Intervention: Alone (no support)
Number of subjects: 100
Study: 16605566

Group type: EXPERIMENTAL
Intervention: Post-stroke subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 0
Study: 11965271

Group type: EXPERIMENTAL
Intervention: Nicorandil 20 mg twice daily
Number of subjects: 5126

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5126
Study: 9802528

Group type: EXPERIMENTAL
Intervention: Drinking frequency (number of days drinking)
Number of subjects: 569

Group type: EXPERIMENTAL
Intervention: Drinking intensity (drinks per drinking day)
Number of subjects: 569
Study: 8707437

Group type: EXPERIMENTAL
Intervention: Indium‐111 monoclonal antimyosin antibody imaging
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Follow-up assessment of left ventricular function and antimyosin uptake
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Assessment of left ventricular function
Number of subjects: 10
Study: 2387950

Group type: EXPERIMENTAL
Intervention: Calcium (1.558 g) and vitamin D (45 micrograms or 1,800 IU) administered daily for 11 weeks
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 139
Study: 64746

Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Dextran 40
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Xantinol nicotinate
Number of subjects: 382

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 382
Study: 7325347

Group type: EXPERIMENTAL
Intervention: 0.3 mg Buprenorphine (Temgesic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 10 mg Nicomorphine (Vilan)
Number of subjects: 0
Study: 30771856

Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation (folic acid [5 mg], B12 [0.4 mg], B6 [50 mg])
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: B-vitamin supplementation
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 30541593

Group type: EXPERIMENTAL
Intervention: InBody S10-guided fluid management
Number of subjects: 244

Group type: COMPARATOR
Intervention: Fluid management based only on clinical information
Number of subjects: 244
Study: 27056131

Group type: EXPERIMENTAL
Intervention: Telephone counseling plus self‐help materials
Number of subjects: 1173

Group type: COMPARATOR
Intervention: Self‐help materials only
Number of subjects: 1173
Study: 23890764

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Disulfiram
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of naltrexone/disulfiram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22362401

Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) exercise
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sodium nitroprusside (SNP) infusion
Number of subjects: 6
Study: 19408641

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25%
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with tramadol 100 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 90
Study: 17983123

Group type: EXPERIMENTAL
Intervention: Centric occlusion
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Right eccentric mandibular position
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Heel lift under the right foot
Number of subjects: 45
Study: 16009749

Group type: EXPERIMENTAL
Intervention: Telephone methods for collecting survey data from churches
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of telephone directories and religious sources
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Religious sources alone
Number of subjects: 0
Study: 11914248

Group type: EXPERIMENTAL
Intervention: High-dose intracoronary beta-radiation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 32
Study: 9818750

Group type: EXPERIMENTAL
Intervention: Cefpirome (2 g bd iv)
Number of subjects: 371

Group type: COMPARATOR
Intervention: Ceftazidime (2 g tds iv)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Cefpirome
Number of subjects: 371

Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 371
Study: 7656523

Group type: EXPERIMENTAL
Intervention: Glucagon (1 mg)
Number of subjects: 324

Group type: EXPERIMENTAL
Intervention: Buscopan (20 mg)
Number of subjects: 324

Group type: COMPARATOR
Intervention: Physiological saline (placebo)
Number of subjects: 324
Study: 2669003

Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 798660

Group type: EXPERIMENTAL
Intervention: Dantrium
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Valium
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Combination of Dantrium and Valium
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 30225967

Group type: EXPERIMENTAL
Intervention: Spironolactone (100 mg/d)
Number of subjects: 10
Study: 29345864

Group type: EXPERIMENTAL
Intervention: Naltrexone alone
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Disulfiram and (blinded) naltrexone
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Disulfiram and (blinded) placebo
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo alone
Number of subjects: 254
Study: 26033972

Group type: EXPERIMENTAL
Intervention: rhBMP-12/ACS group (0.015 mg/mL)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard of Care (SOC) group
Number of subjects: 20
Study: 23769170

Group type: EXPERIMENTAL
Intervention: Rinsing the disposable tubing with normal saline and reinfusing it into the donor at the end of each plasma donation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Not rinsing the tubing system and not reinfusing normal saline
Number of subjects: 45
Study: 21455339

Group type: EXPERIMENTAL
Intervention: Aethoxysklerol injection
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Endoscopic hemoclip hemostasis
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Combination of hemoclip hemostasis with aethoxysklerol injection
Number of subjects: 107
Study: 18314118

Group type: EXPERIMENTAL
Intervention: Acupuncture for 25 minutes before and after embryo transfer
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (laid quietly)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 150